www.abbvie.com/oncology.

Contact Information:
Kate Birrenkott
cell: 612-619-0648
Kate.Birrenkott@abbvie.com

Virtual Exhibit Hall Home

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established
pharmaceutical leader. At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge technologies, and by working together with our partners – scientists, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in treatment across some of the most debilitating and widespread cancers. We are also committed to exploring solutions to help patients obtain access to our cancer medicines. AbbVie's oncology portfolio now consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 300 clinical trials and more than 20 different tumor types.

For more information, please visit http://www.abbvie.com/oncology.

Material Links
AbbVie Website
Product Prescribing Information
CLL Website
AML Website
CLL Treatment Guide
AML Treatment Guide